Ingenovis Health acquires healthcare staffing company

Ingenovis Health, a tech-enabled platform for healthcare staffing, has acquired another healthcare staffing platform, HealthCare Support.

Ingenovis is backed by private investment firms Cornell Capital and Trilantic North America and was formed by a combination of trustaff, CardioSolution, Fastaff Travel Nursing, U.S. Nursing Corporation and Stella.ai. It is one of the fastest-growing providers of healthcare staffing, according to the announcement. HealthCare Support, based in Orlando, Florida, was founded in 2003 and has since grown into one of the largest allied healthcare staffing companies in the country.

The acquisition comes as Ingenovis is still in growth mode through both acquisitions and organic growth.

"The acquisition of HSS will further enhance and diversify the Ingenovis platform as we execute our targeted acquisitive growth strategy," Stephen Trevor, partner of Cornell Capital, and Jeremy Lynch, partner of Trilantic North America, said in a statement. "HSS has been a consistent outperformer with its client-centric business model and scalable, cloud-based technology infrastructure. Together, the combined business is well positioned to continue capturing market share and driving greater impact for clients across the healthcare industry."

The deal also comes as the healthcare industry faces a labor shortage in a tight workforce environment. The COVID-19 pandemic has strained the availability of eligible healthcare workers and influenced many to quit the industry altogether.

"This is a pivotal time for the healthcare industry, and we see tremendous growth opportunities in joining forces with Ingenovis to enhance its leadership in healthcare staffing," said Chris Abel, President of HealthCare Support. 

The acquisition is expected to close in the first quarter of 2022, subject to regulatory approvals and other customary closing conditions.

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”